Chronic Myelomonocytic Leukemia - 28 Studies Found
Completed |
: Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) :
: 2010-01-12 : |
Completed |
: Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia :
|
Active, not recruiting |
: Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) :
|
Recruiting |
: SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia) :
: |
RECRUITING |
: Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia : Recurrent Chronic Myelomonocytic Leukemia : 2024-05-23 : Undergo collection of blood samples |
RECRUITING |
: Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm : Chronic Myelomonocytic Leukemia : 2024-05-23 : Undergo collection of blood and buccal samples |
NOT_YET_RECRUITING |
: Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. : Chronic Myelomonocytic Leukemia : 2024-05-23 : CD4CAR cells transduced with a lentiviral vector to express the single-chain variable fragment (scFv) nucleotide sequence of the anti-CD4 molecule der |